ACE inhibitors and ARBs Flashcards
1
Q
ACE inhibitors
A
Benazepril Captopril Enalapril Enalaprilat Fosinopril Lisinopril Moexipril Perindopril Quinapril Ramipril Trandolapril
2
Q
Angiotensin receptor blockers
A
Azilsartan Candesartan Eprosartan Irbesartan Losartan Olmesartan Telmisartan Valsartan
3
Q
Drugs that block renin secretion
A
Clonidine
propranolol
4
Q
Renin inhibitor
A
Aliskiren
5
Q
Renin
A
- Aspartyl protease
- Catalyzes conversion of angiotensinogen to angiotensin 1
- Synthesized and stored in the juxtaglomerular apparatus of the nephron
- Sympathetic stimulation activates B1 adrenergic receptors on juxtaglomerular cells, stimulates the release of renin
6
Q
Angiotensinogen
A
- Synthesized in the liver
- Cleaved by renin into angiotensin 1
- Angiotensinogen increased by corticosteroids, estrogens, thyroid hormones, and angiotensin II
7
Q
Angiotensin I
A
- Cleaved to angiotensin II by angiotensin converting enzyme (ACE)
- Pharmacological responses to these peptides are indistinguishable due to the rapid conversion
8
Q
Angiotensin II
A
- Exerts actions at vascular smooth muscle (contraction), adrenal cortex (aldosterone synthesis), kidney (renin secretion inhibition), heart (hypertrophy), and brain (reset baroreceptor)
- Angiotensin II 40x more potent vasoconstrictor than epi
- Most active angiotensin peptide
- Activates GPCR angiotensin II receptor
- Rate determined by renin
- Removed rapidly by angiotensinase
9
Q
Converting Enzyme (ACE)
A
- Converts angiotensin I to angiotensin II
- Bradykinin (vasodilator) is inactivated by ACE
- Widely distributed and on luminal surface of vascular endothelial cells
10
Q
Angiotensin II receptors
A
- AT1 is the major receptor in adults. AT2 is also a receptor. Both GPCR
- AT1 is Gq activating IP3 and DAG causing smooth muscle contraction
- AT2 activates bradykinin and NO causing vasodilation
11
Q
Aldosterone
A
- Promotes reabsorption of Na from distal convoluted tubule
- Increases ENaC and Na/K ATPase to increase Na reabsorption and K secretion
- Causes increased H2O retention, increased blood volume, increased BP and hypokalemia
12
Q
What drugs inhibit the RAAS system?
A
Ace inhibitors and ARBs
13
Q
ACEIs MOA
A
- Inhibition of ACE to conversion to angiotensin II
- Lower BP by decreasing peripheral vascular resistance
- They don’t impact cardiac output or HR
- Approved for HTN, nephropathy, heart failure, left ventricular dysfunction, AMI, prophylaxis of cardiovascular events
- Dosing based on half life
14
Q
Angiotensin receptor blockers (ARBs) MOA
A
- Selective blockade of AT1-type receptors
- No effect on bradykinin metabolism
- Tx for HTN, diabetic nephropathy, HF, left ventricular dysfunction, prophylaxis of cardiovascular events
- Blockade of angiotensin II induced contraction of vascular smooth muscle, pressor responses, aldosterone secretion, changes in renal function, cellular hypertrophy and hyperplasia
15
Q
Differences between ARBs and ACEIs
A
- ARBs reduce activation of AT1 receptors more effectively than do ACEIs
- ARBs permit activation of AT2 receptors
- ACEIs increase the levels of number of ACE substrates including bradykinin